NHC · National Healthcare Corp

$222.70 +0.44 (+0.20%) At close · Aug 28

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$3.48B

15.66M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-2

Net shares bought

-0.06%

Net buy value

-$2,081,744

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-25	Gifford David R.	Director	Sell↓	Common Stock	1,779	$225.42	$401,022	1,030
2026-08-20	Gifford David R.	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	6,479	—	—	0
2026-08-20	Gifford David R.	Director	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	6,479	$171.42	$1,110,630	7,500
2026-08-20	Gifford David R.	Director	Award↓ Filing footnotes — Common Stock (Direct) Shares were withheld by the Company to pay the exercise price. Total amount of shares beneficially owned following transactions reported on this form.	Common Stock	4,691	$236.75	$1,110,594	2,809
2026-08-19	Flatt Stephen Fowler	Director, CEO	Sell↓	Common Stock	1,500	$237.08	$355,620	65,487
2026-08-13	Gifford David R.	Director	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	1,021	$171.42	$175,020	1,021
2026-08-13	Gifford David R.	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	1,021	—	—	6,479
2026-06-22	HASSAN EMIL E	Director	Sell↓	Shares of Common Stock	5,937	$200.00	$1,187,400	65,595
2026-06-16	HASSAN EMIL E	Director	Sell↓	Shares of Common Stock	1,563	$199.98	$312,561	71,532
2026-06-16	KIDD BRIAN F	SVP, CFO	Gift↓	Common Stock	500	—	—	29,996
2026-06-08	ADAMS ROBERT G	Director	Convert↑ Filing footnotes — Shares of Common Stock - Trust I (Indirect) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Shares of Common Stock - Trust I (I)	4,000	$69.19	$276,760	17,579
2026-06-08	ADAMS ROBERT G	Director	Gift↓ Filing footnotes — Shares of Common Stock - Trust I (Indirect) Total amount of shares beneficially owned following transactions reported on this form.	Shares of Common Stock - Trust I (I)	4,000	—	—	13,579
2026-06-08	ADAMS ROBERT G	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2022 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2022 Grant]	4,000	—	—	3,500
2026-06-01	Piercey Lisa	Director	Buy↑	Common Stock	949	$184.26	$174,859	949
2026-05-22	FLATT BEN ANDERSON SR	Senior VP & CIO	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	4,000	—	—	4,000
2026-05-22	FLATT BEN ANDERSON SR	Senior VP & CIO	Tax↓ Filing footnotes — Common Stock (Direct) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.	Common Stock	2,739	$196.00	$536,844	22,636
2026-05-22	FLATT BEN ANDERSON SR	Senior VP & CIO	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	4,000	$94.10	$376,400	25,375
2026-05-21	LAROCHE RICHARD F JR	Director	Sell↓	Common Stock - Held in my name or my wife's name	7,500	$195.14	$1,463,566	205,760
2026-05-20	Flatt Stephen Fowler	Director, CEO	Gift↓	Common Stock	26	—	—	66,987
2026-05-19	Shelly Timothy J.	Sr.VP Operations	Sell↓	Common Stock	1,853	$197.22	$365,444	1,294
2026-05-14	Flatt Stephen Fowler	Director, CEO	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	5,000	$94.10	$470,500	70,505
2026-05-14	KIDD BRIAN F	SVP, CFO	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	500	$90.62	$45,310	33,630
2026-05-14	KIDD BRIAN F	SVP, CFO	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	4,000	—	—	4,000
2026-05-14	Flatt Stephen Fowler	Director, CEO	Tax↓ Filing footnotes — Common Stock (Direct) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.	Common Stock	4,492	$197.96	$889,236	67,013
2026-05-14	Flatt Stephen Fowler	Director, CEO	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	1,000	$90.62	$90,620	71,505
2026-05-14	Flatt Stephen Fowler	Director, CEO	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	5,000	—	—	5,000
2026-05-14	KIDD BRIAN F	SVP, CFO	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	500	—	—	9,000
2026-05-14	KIDD BRIAN F	SVP, CFO	Convert↑ Filing footnotes — Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock	4,000	$94.10	$376,400	33,130
2026-05-14	KIDD BRIAN F	SVP, CFO	Tax↓ Filing footnotes — Common Stock (Direct) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.	Common Stock	3,134	$197.96	$620,407	30,496
2026-05-14	Flatt Stephen Fowler	Director, CEO	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	1,000	—	—	12,000
2026-05-07	ABERNATHY JAMES PAUL	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	ADAMS ROBERT G	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	Trail Sandra Y.	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	LAROCHE RICHARD F JR	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	Gifford David R.	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	Adams William A.	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) previous Form 4 price of the option was not entered correctly it was originally entered at $0.00. The price is the closing as of 5/7/2026 ($171.42) this is corrected on this Form 4/A.	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	HASSAN EMIL E	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-07	Piercey Lisa	Director	Award↑ Filing footnotes — Option to Purchase Common Stock [2026 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2026 Grant]	7,500	—	—	7,500
2026-05-06	Trail Sandra Y.	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2023 Grant] (Direct) These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2023 Grant]	3,140	—	—	4,360
2026-05-06	Trail Sandra Y.	Director	Convert↑ Filing footnotes — Shares of Common Stock (Direct) These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Shares of Common Stock	3,140	$55.75	$175,055	10,640
2026-05-05	LAROCHE RICHARD F JR	Director	Convert↑ Filing footnotes — Common Stock - Held in my name or my wife's name (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Common Stock - Held in my name or my wife's name	7,500	$71.64	$537,300	213,260
2026-05-05	LAROCHE RICHARD F JR	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2021 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2021 Grant]	7,500	—	—	0
2026-04-30	HASSAN EMIL E	Director	Convert↑ Filing footnotes — Shares of Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Shares of Common Stock	7,500	$71.64	$537,300	73,095
2026-04-30	HASSAN EMIL E	Director	Convert↓ Filing footnotes — Option to Purchase Common Stock [2021 Grant] (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock [2021 Grant]	7,500	—	—	0
2026-04-22	Dodson Vicki L	Sr.VP Patient Srvcs	Convert↑ Filing footnotes — Shares of Common Stock held in my name (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Shares of Common Stock held in my name	4,000	$94.10	$376,400	18,412
2026-04-22	Dodson Vicki L	Sr.VP Patient Srvcs	Tax↓ Filing footnotes — Shares of Common Stock held in my name (Direct) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.	Shares of Common Stock held in my name	2,853	$173.63	$495,366	15,559
2026-04-22	Dodson Vicki L	Sr.VP Patient Srvcs	Convert↓ Filing footnotes — Option to Purchase Common Stock (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Option to Purchase Common Stock	4,000	—	—	4,000
2026-04-09	FLATT BEN ANDERSON SR	Senior VP & CIO	Tax↓ Filing footnotes — Common Stock (Direct) On April 13, 2026, the reporting person filed a Form 4 mistakenly reporting the number of shares withheld by the Company to pay the exercise price and withholding tax obligations. The total shares that were withheld by the Company to pay the exercise price and withholding tax obligations are reflected correctly on this amended Form 4. Total amount of shares beneficially owned following transactions reported on this form.	Common Stock	2,109	$176.81	$372,892	21,175
2026-03-16	Dodson Vicki L	Sr.VP Patient Srvcs	Convert↑ Filing footnotes — Shares of Common Stock held in my name (Direct) These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).	Shares of Common Stock held in my name	3,734	$53.94	$201,412	16,446
2026-03-16	Dodson Vicki L	Sr.VP Patient Srvcs	Tax↓ Filing footnotes — Shares of Common Stock held in my name (Direct) Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Total amount of shares beneficially owned following transactions reported on this form.	Shares of Common Stock held in my name	2,034	$164.96	$335,529	14,412

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 566 transactions

Key facts CIK 1047335 CUSIP 635906100 13F (30d) 212 filings 199 filers Visit website